Partnering with Clinical Pharmacologists to Improve Medication Use in Children.
作者信息
Miyagi Shogo John, Lam Edwin, Tang Girdwood Sonya
机构信息
T32 Pediatric Clinical Pharmacology Training Program, Pediatric Clinical and Developmental Pharmacology Training Network, National Institute of Child Health and Human Development, Rockville, MD; Divisions of Clinical Pharmacology and Pharmacy, Children's National Medical Center, Washington, DC.
T32 Pediatric Clinical Pharmacology Training Program, Pediatric Clinical and Developmental Pharmacology Training Network, National Institute of Child Health and Human Development, Rockville, MD; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA.
出版信息
J Pediatr. 2020 Dec;227:5-8. doi: 10.1016/j.jpeds.2020.03.061.
Abstract
摘要
相似文献
1
Partnering with Clinical Pharmacologists to Improve Medication Use in Children.与临床药理学家合作以改善儿童用药情况。
J Pediatr. 2020 Dec;227:5-8. doi: 10.1016/j.jpeds.2020.03.061.
2
Summaries of Safety Labeling Changes Approved By FDA--Boxed Warnings Highlights July--September 2015.美国食品药品监督管理局（FDA）批准的安全标签变更摘要——黑框警告要点 2015 年 7 月至 9 月
Am J Health Syst Pharm. 2015 Dec 1;72(23):2008. doi: 10.2146/news150081.
3
Improving Medicine Use for Children: A Global Imperative.改善儿童用药：全球当务之急。
Clin Pharmacol Ther. 2017 Jun;101(6):715-717. doi: 10.1002/cpt.635. Epub 2017 Mar 20.
4
Drugs for Children.儿童用药
Clin Pharmacol Ther. 2017 Jun;101(6):704-706. doi: 10.1002/cpt.675.
5
Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.儿童药物不良反应：治疗的双刃剑。
Clin Pharmacol Ther. 2017 Jun;101(6):725-735. doi: 10.1002/cpt.677. Epub 2017 Apr 29.
6
Dosage Adjustments Related to Young or Old Age and Organ Impairment.与年龄（年轻或年老）及器官损害相关的剂量调整。
J Clin Pharmacol. 2016 Dec;56(12):1461-1473. doi: 10.1002/jcph.816. Epub 2016 Sep 22.
7
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.儿科病房药物的超说明书用药与药物不良反应：一项前瞻性多中心研究
Curr Drug Saf. 2018;13(3):200-207. doi: 10.2174/1574886313666180619120406.
8
Pediatric Off-Label and Unlicensed Drug Use and Its Implications.儿科药物的超说明书使用及未获许可药物使用及其影响。
Curr Clin Pharmacol. 2017;12(1):18-25. doi: 10.2174/1574884712666170317161935.
9
Off-label and unlicensed prescribing for children: have we made any progress?儿童超说明书用药和无许可证用药：我们有进展吗？
Br J Clin Pharmacol. 2007 Jul;64(1):1-2. doi: 10.1111/j.1365-2125.2007.02987.x.
10
Paediatric clinical pharmacology: at the beginning of a new era.儿科临床药理学：新时代的开端。
Eur J Clin Pharmacol. 2008 Feb;64(2):201-5. doi: 10.1007/s00228-007-0390-5. Epub 2007 Oct 31.
本文引用的文献
1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.他克莫司治疗药物监测-个体化治疗：第二版共识报告。
Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640.
2
Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients.成人肝移植患者中两种他克莫司制剂的群体药代动力学模型及贝叶斯估计器
Br J Clin Pharmacol. 2019 Aug;85(8):1740-1750. doi: 10.1111/bcp.13960. Epub 2019 Jun 14.
3
Significant effect of infection and food intake on sirolimus pharmacokinetics and exposure in pediatric patients with acute lymphoblastic leukemia.感染和饮食对急性淋巴细胞白血病患儿西罗莫司药代动力学和暴露量的显著影响。
Eur J Pharm Sci. 2019 Feb 1;128:209-214. doi: 10.1016/j.ejps.2018.12.004. Epub 2018 Dec 8.
4
Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.美国儿科研究公平法案下强制性儿科上市后研究的完成率和报告情况。
JAMA Pediatr. 2019 Jan 1;173(1):68-74. doi: 10.1001/jamapediatrics.2018.3416.
5
Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments.跨年龄连续体的药物不良反应：流行病学、诊断挑战、预防和治疗。
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S36-S47. doi: 10.1002/jcph.1115.
6
A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation.儿童实体器官移植后基于年龄和基因型指导的他克莫司给药随机临床试验。
Pediatr Transplant. 2018 Nov;22(7):e13285. doi: 10.1111/petr.13285. Epub 2018 Sep 3.
7
Families of Children With Medical Complexity: A View From the Front Lines.患有复杂疾病儿童的家庭：来自前线的观点。
Pediatrics. 2018 Mar;141(Suppl 3):S195-S201. doi: 10.1542/peds.2017-1284D.
8
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies.基于模型的西罗莫司精准剂量给药在儿科血管异常患者中的应用。
Eur J Pharm Sci. 2017 Nov 15;109S:S124-S131. doi: 10.1016/j.ejps.2017.05.037. Epub 2017 May 17.
9
An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings.
Clin Pharmacol Ther. 2017 Feb;101(2):274-280. doi: 10.1002/cpt.460. Epub 2016 Sep 28.
10
Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.基因型指导给药可使接受造血干细胞移植的儿科患者伏立康唑水平达到优化。
Biol Blood Marrow Transplant. 2016 Mar;22(3):482-6. doi: 10.1016/j.bbmt.2015.11.011. Epub 2015 Nov 23.
Zotero 插件